Company News

Cybin Inc announces oversubscribed private placement

Cybin Inc announces it has signed an LOI with XXX corp and plans reverse merger on the CSE

Cybin Inc announces it has commenced preliminary work on Phase I clinical trials

Industry News

Oregon

Denver

Oakland

Canada

FDA

Address

100 King St West, Suite 5600
Toronto, ON M5X 1C9

Contact

Email: info@cybin.com
 

© 2019 Cybin Inc